✦ LIBER ✦

Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question

✍ Scribed by Ferrari, Michel D.; Wilkinson, Marcia; Hirt, Dorothea; Lataste, Xavier; Notter, Marianne

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of ICS 205-930, a new 5-HT3

✍ H. Kameda; M. Minami; M. Yoshioka; H. Saito 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 102 KB

A randomized, multicenter study comparin

✍ Bengt G. Sorbe; Thomas Högberg; Bengt Glimelius; Margareta Schmidt; Lars Wernste 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 900 KB

O3-04-06: Efficacy and tolerability of S

✍ Marina Zvartau-Hind; Gareth Maher-Edwards; Jackie Hunter; Michael Gold; Gillian 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Efficacy of an Ondansetron Orally Disint

✍ J.P. LeBourgeois; C.J. McKenna; B. Coster; P. Feyer; L. Franzén; L. Goedhals; Z. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 140 KB